| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| codeine phosphate hemihydrate | Oral Liquid, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 12/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| nortriptyline | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| bethanechol chloride | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/09/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 12/09/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| quetiapine fumarate | Tablet, modified release | 230.26 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| adefovir dipivoxil | Tablet | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/09/2025 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 12/09/2025 |
| acarbose | Tablet | 100 mg | Current | Limited Availability | Manufacturing | 12/09/2025 |
| levetiracetam | Solution | 100 mg/mL | Current | Limited Availability | Manufacturing | 12/09/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 12/09/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 12/09/2025 |
| irbesartan | Tablet, film coated | 150 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| mebeverine hydrochloride | Tablet, film coated | 135 mg | Current | Unavailable | Manufacturing | 12/09/2025 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Anticipated | Available | Manufacturing | 12/09/2025 |
| eplerenone | Tablet, film coated | 25 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| midazolam maleate | Solution | 10.2 mg | Current | Limited Availability | Manufacturing | 12/09/2025 |
| ramipril | Tablet, uncoated | 1.25 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 12/09/2025 |
| indocyanine green | Injection, powder for | 25 mg | Resolved | Available | Manufacturing | 12/09/2025 |
| phenytoin sodium | Injection, solution | 250 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~26.9 mg | Current | Limited Availability | Manufacturing | 12/09/2025 |
| dosulepin hydrochloride | Tablet, film coated | 75 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| valaciclovir hydrochloride | Tablet, film coated | 1112 mg | Anticipated | Available | Manufacturing | 12/09/2025 |
| trandolapril | Capsule | 4 mg | Current | Limited Availability | Manufacturing | 12/09/2025 |
| naproxen | Tablet, modified release | 750 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| propranolol hydrochloride | Tablet, film coated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/09/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/09/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 11/09/2025 |
| olsalazine sodium | Capsule | 250 mg | Current | Unavailable | Manufacturing | 11/09/2025 |
| octreotide | Injection, solution | 500 microgram | Current | Limited Availability | Manufacturing | 11/09/2025 |
| tramadol hydrochloride | Tablet, modified release | 200 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Current | Limited Availability | Manufacturing | 11/09/2025 |
| phenoxymethylpenicillin potassium | Oral Liquid, powder for | 28.284 mg/mL | Current | Limited Availability | Manufacturing | 11/09/2025 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 11/09/2025 |
| riluzole | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| allopurinol | Tablet | 300 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/09/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/09/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| fenofibrate | Tablet, film coated | 145 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| lacosamide | Tablet, film coated | 100 mg | Current | Limited Availability | Manufacturing | 11/09/2025 |
| metoprolol succinate | Tablet, modified release | 47.5 mg | Resolved | Available | Manufacturing | 11/09/2025 |
| Teriparatide | Injection, solution | .25 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/09/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 11/09/2025 |
| Teriparatide | Injection, solution | 250 microgram/mL | Current | Unavailable | Manufacturing | 11/09/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 1000 mg~56.69 mg | Current | Unavailable | Manufacturing | 11/09/2025 |
| olsalazine sodium | Tablet, uncoated | 500 mg | Current | Unavailable | Manufacturing | 11/09/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 3.09 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/09/2025 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| venlafaxine | Capsule, modified release | 150 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 10/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 10 mg | Current | Limited Availability | Manufacturing | 10/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 200 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 10/09/2025 |
| capecitabine | Tablet, film coated | 500 mg | Discontinued | Unavailable | Manufacturing | 10/09/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~10 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| naproxen | Tablet, modified release | 1000 mg | Resolved | Available | Manufacturing | 10/09/2025 |
| naproxen | Tablet, modified release | 750 mg | Resolved | Available | Manufacturing | 10/09/2025 |
| atenolol | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| azacitidine | Injection, powder for | 100 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 10/09/2025 |
| rifampicin | Capsule, hard | 150 mg | Current | Limited Availability | Manufacturing | 10/09/2025 |
| rifampicin | Capsule, hard | 300 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Current | Limited Availability | Manufacturing | 10/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 30 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Unavailable | Manufacturing | 10/09/2025 |
| tramadol hydrochloride | Capsule | 50 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| acetylcysteine | Injection, concentrated | 2 g | Anticipated | Available | Manufacturing | 9/09/2025 |
| octreotide | Injection, solution | 100 microgram | Current | Limited Availability | Manufacturing | 9/09/2025 |
| octreotide | Injection, solution | 50 microgram | Current | Limited Availability | Manufacturing | 9/09/2025 |
| leflunomide | Tablet, film coated | 20 mg | Anticipated | Available | Manufacturing | 9/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 9/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 9/09/2025 |
| ceftaroline fosamil | Injection, powder for | 600 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Current | Unavailable | Manufacturing | 9/09/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 10.844 mg~13.88 mg | Current | Unavailable | Manufacturing | 9/09/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 43.376 mg~13.88 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| midazolam | Injection, solution | 50 mg | Anticipated | Available | Manufacturing | 9/09/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 9/09/2025 |
| amiodarone hydrochloride | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 9/09/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 9/09/2025 |
| spironolactone | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| proguanil hydrochloride~atovaquone | Tablet, film coated | 100 mg~250 mg | Resolved | Available | Manufacturing | 9/09/2025 |
| labetalol hydrochloride | Tablet, film coated | 100 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Resolved | Available | Manufacturing | 9/09/2025 |
| nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 9/09/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Resolved | Available | Manufacturing | 8/09/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Resolved | Available | Manufacturing | 8/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/09/2025 |
| carboplatin | Injection, solution | 450 mg | Resolved | Available | Manufacturing | 8/09/2025 |
| Trastuzumab | Injection, solution | 600 mg | Anticipated | Available | Manufacturing | 8/09/2025 |
| lacosamide | Tablet, film coated | 150 mg | Current | Limited Availability | Manufacturing | 8/09/2025 |
| sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 8/09/2025 |
| desmopressin acetate | Spray, solution | .1 mg/mL | Current | Unavailable | Product recall | 8/09/2025 |
| spironolactone | Tablet, film coated | 100 mg | Anticipated | Available | Manufacturing | 8/09/2025 |
| methyl aminolevulinate hydrochloride | Cream | 200 mg/g | Current | Limited Availability | Manufacturing | 8/09/2025 |
2025年9月15日